As a severe neurological disease, Rett syndrome (RTT) leads to neurodevelopmental abnormalities in this crucial period, primarily arising from de novo mutations in the X-chromosomal methyl-CpG binding protein gene 2 (MECP2) (3–5). This evidence concerns the gene MECP2 and atypical Rett syndrome.